Exhibit 99.1

InMode Reports Second Quarter 2026 Financial Results:
Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025

YOKNEAM, Israel, August 5, 2026 - InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter of 2026.
 
Second Quarter 2026 Highlights:

 
●          Quarterly GAAP revenues of $95.6 million, consistent with the second quarter of 2025.
 
●          Quarterly revenues from consumables and service of $22.3 million, an increase of 13% compared to the second quarter of 2025.
●          GAAP operating income of $12.3 million and *non-GAAP operating income of $16.0 million.
●          Total cash position of $501.1 million as of June 30, 2026, including cash and cash equivalents, marketable securities and short-term bank deposits.
●          Completed the repurchase of 6.38 million ordinary shares for an aggregate purchase price of $87.8 million through the previously announced share repurchase program.

U.S. GAAP Results
(U.S. dollars in thousands, except for per share data)
 
Q2 2026
Q2 2025
Revenues
$95,589
$95,602
Gross Margins
75%
80%
Operating Margins
13%
24%
Net Income
$17,064
$26,742
Earnings per Diluted Share
$0.29
$0.42
*Non-GAAP Results
(U.S. dollars in thousands, except for per share data)
 
Q2 2026
Q2 2025
Gross Margins
75%
80%
Operating Margins
17%
28%
Net Income
$20,812
$30,139
Earnings per Diluted Share
$0.35
$0.47

*Please refer to “Use of non-GAAP Financial Measures” below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements included in this release. Non-GAAP results exclude share-based compensation, expenses related to independent transaction committee review (representing non-recurring cost) and related income tax adjustments where applicable.
 
Management Comments

“Overall revenue was consistent with the prior-year period, and we saw continued stability in our U.S. capital equipment business, reflecting steady customer demand. This performance is consistent with the stabilization we anticipate will continue through the remainder of the year. We remain focused on investing in opportunities that support long-term growth,” said Moshik Itzkovich, Chief Financial Officer of InMode.

Second Quarter 2026 Financial Results

Total GAAP revenues for the second quarter of 2026 were $95.6 million, consistent with the second quarter of 2025. Revenue from Asia reached a quarterly record, reflecting continued strength across key markets in the region. Quarterly revenues from consumables and service grew 13% compared to the second quarter of 2025, to $22.3 million, derived primarily from international sales.


GAAP gross margin for the second quarter of 2026 was 75%, compared to 80% for the second quarter of 2025.
*Non-GAAP gross margin for the second quarter of 2026 was 75%, compared to 80% for the second quarter of 2025.

GAAP operating margin for the second quarter of 2026 was 13%, compared to 24% for the second quarter of 2025. *Non-GAAP operating margin for the second quarter of 2026 was 17%, compared to 28% for the second quarter of 2025. These decreases were primarily attributable to higher cost of goods sold, product mix, the restructuring of the North America sales team implemented toward the end of 2025, additional marketing and sales investments to retain talent and maintain market share, and higher general and administrative expenses driven by increased professional services costs. We expect these trends to continue for the foreseeable future.
 
InMode reported GAAP net income of $17.1 million, or $0.29 per diluted share, in the second quarter of 2026, compared to $26.7 million, or $0.42 per diluted share, in the second quarter of 2025. On a *non-GAAP basis, InMode reported net income of $20.8 million, or $0.35 per diluted share, in the second quarter of 2026, compared to $30.1 million, or $0.47 per diluted share, in the second quarter of 2025.
 
As of June 30, 2026, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $501.1 million.
 
Appointed New Chief Financial Officer and New Board Director

On May 20, 2026, the Company announced the appointment of Dr. Shlomo Nass as its new Chairman of the Company’s Board of Directors, effective May 19, 2026. The Company also announced the appointment of Moshe (Moshik) Itzkovich as the Company’s new Chief Financial Officer, effective May 19, 2026, while former Chief Financial Officer Yair Malca continues to be engaged with the Company as a consultant.

2026 Financial Outlook
 
Management provided an outlook for the full fiscal year ending December 31, 2026. Based on current estimates, management expects:

Revenues between $365 million and $375 million
*Non-GAAP gross margin between 74% and 76%
*Non-GAAP income from operations to be between $68 million and $73 million
*Non-GAAP earnings per diluted share between $1.29 and $1.34
 
However, these expectations are based on management’s current estimates, which may be updated.
 
This outlook is not a guarantee of future performance, and shareholders should not rely on such forward-looking statements. See “Forward-Looking Statements” for additional information.
 
*Please refer to “Use of non-GAAP Financial Measures” below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation, expenses related to independent transaction committee review (representing non-recurring cost) and related income tax adjustments where applicable.
 

Conference Call and Webcast Update

As previously announced, while the Company’s Special Committee continues its evaluation of unsolicited proposals, the Company will not host an investor conference call or webcast in connection with this earnings release and will not be conducting investor meetings at this time.



The Current Situation in Israel

The scope and severity of ongoing conflicts in Gaza, Northern Israel, Lebanon, Iran, and the broader region are unpredictable and could escalate at any time. To date, our operations have not been materially affected. We continue to monitor political and military developments closely and examine the consequences for our operations and assets. 
 
Use of Non-GAAP Financial Measures

In addition to InMode’s operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin, non-GAAP gross margin and non-GAAP income from operations. Because these measures are used in InMode’s internal analysis of financial and operating performance, management believes they provide investors with greater transparency into its view of InMode’s economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode’s GAAP operating results, allows investors to more effectively evaluate and compare InMode’s performance to that of its peers, although InMode’s presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release. Reconciliations of non-GAAP gross margin, non-GAAP income from operations, and non-GAAP earnings per diluted share for management’s projections of such non-GAAP financials for the 2026 fiscal year are not available without unreasonable effort due to the variability, complexity and limited visibility of certain reconciling items. These reconciling items could have a significant and unpredictable impact on our future GAAP results.
 
About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency (“RF”) technology. InMode strives to enable emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Forward-Looking Statements

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode’s future financial or operating performance, including the actual amount of share repurchases made by the Company, if any. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “would” and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management’s current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2026, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

Company Contact:
Moshik Itzkovich
Chief Financial Officer
Email: Moshik.Itzkovich@inmodemd.com
Investor Relations Contact:
Miri Segal
MS-IR LLC
Email: ir@inmodemd.com



INMODE LTD.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(U.S. dollars in thousands, except for per share data)
(Unaudited)

 
Three months ended
   
Six months ended
 
   
June 30,
   
June 30,
 
   
2026
   
2025
   
2026
   
2025
 
REVENUES
   
95,589
     
95,602
     
177,606
     
173,476
 
COST OF REVENUES
   
24,073
     
19,152
     
44,538
     
36,115
 
GROSS PROFIT
   
71,516
     
76,450
     
133,068
     
137,361
 
OPERATING EXPENSES:
                               
Research and development
   
3,656
     
3,372
     
7,198
     
6,267
 
Sales and marketing
   
50,818
     
47,474
     
93,750
     
87,201
 
General and administrative
   
4,785
     
2,723
     
9,807
     
5,394
 
TOTAL OPERATING EXPENSES
   
59,259
     
53,569
     
110,755
     
98,862
 
OPERATING INCOME
   
12,257
     
22,881
     
22,313
     
38,499
 
Finance income, net
   
7,432
     
8,062
     
11,728
     
14,921
 
INCOME BEFORE INCOME TAXES
   
19,689
     
30,943
     
34,041
     
53,420
 
INCOME TAXES
   
2,625
     
4,201
     
5,415
     
8,477
 
NET INCOME
   
17,064
     
26,742
     
28,626
     
44,943
 
 
                               
EARNINGS PER SHARE:
                               
Basic
   
0.29
     
0.42
     
0.47
     
0.68
 
Diluted
   
0.29
     
0.42
     
0.46
     
0.68
 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE (in thousands)
                               
Basic
   
58,903
     
63,252
     
61,140
     
65,982
 
Diluted
   
59,378
     
63,637
     
61,717
     
66,540
 


INMODE LTD.
CONDENSED CONSOLIDATED BALANCE SHEETS
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
June 30,
2026
   
December 31,
2025
 
Assets
           
CURRENT ASSETS:
           
Cash and cash equivalents
   
396,173
     
302,543
 
Marketable securities
   
18,995
     
83,632
 
Short-term bank deposits
   
85,947
     
169,159
 
Accounts receivable, net of allowance for credit losses
   
44,555
     
43,504
 
Prepaid expenses and other receivables
   
32,664
     
25,733
 
Inventories
   
71,661
     
74,050
 
         TOTAL CURRENT ASSETS
   
649,995
     
698,621
 
    NON-CURRENT ASSETS:
               
Accounts receivable, net of allowance for credit losses
   
5,686
     
3,005
 
Deferred income tax assets
   
52,629
     
53,230
 
Operating lease right-of-use assets
   
8,693
     
8,274
 
Property and equipment, net
   
2,628
     
2,599
 
Other investments
   
700
     
700
 
TOTAL NON-CURRENT ASSETS
   
70,336
     
67,808
 
TOTAL ASSETS
   
720,331
     
766,429
 
Liabilities and shareholders’ equity
               
CURRENT LIABILITIES:
               
Accounts payables
   
18,792
     
17,912
 
Contract liabilities
   
15,452
     
12,093
 
Other liabilities
   
45,193
     
40,739
 
TOTAL CURRENT LIABILITIES
   
79,437
     
70,744
 
    NON-CURRENT LIABILITIES:
               
Contract liabilities
   
2,484
     
3,043
 
Other liabilities
   
4,825
     
4,436
 
Operating lease liabilities
   
4,451
     
5,008
 
TOTAL NON-CURRENT LIABILITIES
   
11,760
     
12,487
 
TOTAL LIABILITIES
   
91,197
     
83,231
 
                 
TOTAL SHAREHOLDERS’ EQUITY
   
629,134
     
683,198
 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
   
720,331
     
766,429
 



INMODE LTD.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
Three months ended
June 30,
   
Six months ended
June 30,
 
   
2026
   
2025
   
2026
   
2025
 
CASH FLOWS FROM OPERATING ACTIVITIES:
                       
Net income
   
17,064
     
26,742
     
28,626
     
44,943
 
Adjustments required to reconcile net income to net cash provided by operating activities:
                               
Depreciation and amortization
   
179
     
191
     
354
     
365
 
Share-based compensation expenses
   
3,708
     
3,418
     
6,407
     
5,936
 
Change in allowance for credit losses of trade receivable
   
719
     
147
     
1,244
     
53
 
Loss on marketable securities, net
 
     
5
   
     
3
 
Finance expenses (income), net
   
388
     
(313
)
   
1,107
     
(1,887
)
Deferred income taxes
   
295
     
566
     
622
     
1,462
 
Changes in operating assets and liabilities:
                               
Decrease (increase) in accounts receivable (current and non-current)
   
(5,046
)
   
(3,285
)
   
(4,974
)
   
1,259
 
Decrease (increase) in other receivables
   
(1,164
)
   
1,276
     
(7,030
)
   
(2,256
)
Decrease (increase) in inventories
   
(253
)
   
(4,329
)
   
2,389
     
(8,562
)
Increase in accounts payable
   
1,939
     
2,430
     
880
     
3,700
 
Increase (decrease) in other liabilities (current and non-current)
   
4,400
     
127
     
4,012
     
(3,160
)
Increase (decrease) in contract liabilities (current and non-current)
   
(1,178
)
   
(2,903
)
   
2,800
     
(3,740
)
Net cash provided by operating activities
   
21,051
     
24,072
     
36,437
     
38,116
 
CASH FLOWS FROM INVESTING ACTIVITIES:
                               
   Investment in short-term deposits
   
(85,000
)
   
(25,000
)
   
(169,912
)
   
(25,000
)
   Proceeds from short-term deposits
   
84,912
     
55,000
     
252,570
     
86,297
 
   Purchase of fixed assets
   
(211
)
   
(219
)
   
(383
)
   
(304
)
   Purchase of marketable securities
 
     
-
     
(9,727
)
   
(20,877
)
   Proceeds from sale of marketable securities
 
     
-
   
     
3,003
 
   Proceeds from maturity of marketable securities
   
37,983
     
41,875
     
74,239
     
104,022
 
Net cash provided by investing activities
   
37,684
     
71,656
     
146,787
     
147,141
 
CASH FLOWS FROM FINANCING ACTIVITIES:
                               
Tax withholding related to vesting of restricted share units
   
-
     
-
     
(1,802
)
   
-
 
Repurchase of ordinary shares
   
(56,511
)
   
(27,484
)
   
(87,752
)
   
(127,444
)
Exercise of options
   
19
     
505
     
636
     
999
 
Net cash used in financing activities
   
(56,492
)
   
(26,979
)
   
(88,918
)
   
(126,445
)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
   
(365
)
   
1,540
     
(676
)
   
2,096
 
NET INCREASE IN CASH AND CASH EQUIVALENTS
   
1,878
     
70,289
     
93,630
     
60,908
 
                                 
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
   
394,295
     
145,948
     
302,543
     
155,329
 
CASH AND CASH EQUIVALENTS AT END OF PERIOD
   
396,173
     
216,237
     
396,173
     
216,237
 



INMODE LTD.
CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
Three months ended June 30,
   
Six months ended June 30,
 
    2026     2025     2026     2025  
Revenues by Category:
                                               
                                                 
Capital Equipment revenues - United States
   
43,084
     
45
%
   
40,653
     
42
%
   
76,753
     
43
%
   
70,195
     
40
%
Capital Equipment revenues - International
   
30,194
     
32
%
   
35,133
     
37
%
   
57,179
     
32
%
   
63,266
     
37
%
Total Capital Equipment revenues
   
73,278
     
77
%
   
75,786
     
79
%
   
133,932
     
75
%
   
133,461
     
77
%
Consumables and service revenues
   
22,311
     
23
%
   
19,816
     
21
%
   
43,674
     
25
%
   
40,015
     
23
%
Total Revenue
   
95,589
     
100
%
   
95,602
     
100
%
   
177,606
     
100
%
   
173,476
     
100
%

 
Three months ended June 30,
   
Six months ended June 30,
 
   
2026
   
2025
   
2026
   
2025
 
   
%
   
%
   
%
   
%
 
   
United States
   
International
   
Total
   
United States
   
International
   
Total
   
United States
   
International
   
Total
   
United States
   
International
   
Total
 
Revenues by Technology:
                                                                       
Minimal-Invasive
   
71
     
73
     
73
     
73
     
82
     
78
     
73
     
77
     
75
     
82
     
81
     
81
 
Hands-Free
   
1
     
2
     
1
     
4
     
2
     
3
     
1
     
1
     
1
     
3
     
2
     
3
 
Non-Invasive
   
28
     
25
     
26
     
23
     
16
     
19
     
26
     
22
     
24
     
15
     
17
     
16
 
     
100
     
100
     
100
     
100
     
100
     
100
     
100
     
100
     
100
     
100
     
100
     
100
 


INMODE LTD.
RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF
 INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(U.S. dollars in thousands, except for per share data)
(Unaudited)

   
Three months ended June 30, 2026
   
Three months ended June 30, 2025
 
   
GAAP
   
Stock Based Compensation
   
Non-GAAP
   
GAAP
   
Stock Based Compensation
   
Non-GAAP
 
REVENUES
   
95,589
   
     
95,589
     
95,602
   
     
95,602
 
COST OF REVENUES
   
24,073
     
(302
)
   
23,771
     
19,152
     
(334
)
   
18,818
 
GROSS PROFIT
   
71,516
     
302
     
71,818
     
76,450
     
334
     
76,784
 
OPERATING EXPENSES:
                                               
Research and development
   
3,656
     
(282
)
   
3,374
     
3,372
     
(287
)
   
3,085
 
Sales and marketing
   
50,818
     
(2,525
)
   
48,293
     
47,474
     
(2,529
)
   
44,945
 
General and administrative
   
4,785
     
(599
)
   
4,186
     
2,723
     
(268
)
   
2,455
 
TOTAL OPERATING EXPENSES
   
59,259
     
(3,406
)
   
55,853
     
53,569
     
(3,084
)
   
50,485
 
OPERATING INCOME
   
12,257
     
3,708
     
15,965
     
22,881
     
3,418
     
26,299
 
Finance income, net
   
7,432
   
     
7,432
     
8,062
     
-
     
8,062
 
INCOME BEFORE INCOME TAXES
   
19,689
     
3,708
     
23,397
     
30,943
     
3,418
     
34,361
 
INCOME TAXES
   
2,625
     
(40
)
   
2,585
     
4,201
     
21
     
4,222
 
NET INCOME
   
17,064
     
3,748
     
20,812
     
26,742
     
3,397
     
30,139
 
 
                                               
EARNINGS PER SHARE
                                               
Basic
   
0.29
             
0.35
     
0.42
             
0.48
 
Diluted
   
0.29
             
0.35
     
0.42
             
0.47
 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in Thousands)
                                               
Basic
   
58,903
             
58,903
     
63,252
             
63,252
 
Diluted
   
59,378
             
60,174
     
63,637
             
64,537
 



   
Six months ended June 30, 2026
 
Six months ended June 30, 2025
 
   
GAAP
 
Stock Based Compensation
 
Expenses Related to Independent Transaction Committee Review
 
Non-GAAP
 
GAAP
 
Stock Based Compensation
 
Non-GAAP
REVENUES
 
177,606
 
 
 
177,606
 
173,476
 
-
 
173,476
COST OF REVENUES
 
44,538
 
(616)
 
 
43,922
 
36,115
 
(644)
 
35,471
GROSS PROFIT
 
133,068
 
616
 
 
133,684
 
137,361
 
644
 
138,005
OPERATING EXPENSES:
 
                         
Research and development
 
7,198
 
(550)
 
 
6,648
 
6,267
 
(509)
 
5,758
Sales and marketing
 
93,750
 
(4,386)
 
 
89,364
 
87,201
 
(4,292)
 
82,909
General and administrative
 
9,807
 
(855)
 
(1,262)
 
7,690
 
5,394
 
(491)
 
4,903
TOTAL OPERATING EXPENSES
 
110,755
 
(5,791)
 
(1,262)
 
103,702
 
98,862
 
(5,292)
 
93,570
OPERATING INCOME
 
22,313
 
6,407
 
1,262
 
29,982
 
38,499
 
5,936
 
44,435
Finance income, net
 
11,728
 
 
 
11,728
 
14,921
 
-
 
14,921
INCOME BEFORE INCOME TAXES
 
34,041
 
6,407
 
1,262
 
41,710
 
53,420
 
5,936
 
59,356
INCOME TAXES
 
5,415
 
(389)
 
 
5,026
 
8,477
 
(655)
 
7,822
NET INCOME
 
28,626
 
6,796
 
1,262
 
36,684
 
44,943
 
6,591
 
51,534
 
 
                         
EARNINGS PER SHARE
                           
Basic
 
0.47
         
0.60
 
0.68
     
0.78
Diluted
 
0.46
         
0.59
 
0.68
     
0.77
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in Thousands)
 
                         
Basic
 
61,140
         
61,140
 
65,982
     
65,982
Diluted
 
61,717
         
62,324
 
66,540
     
67,052